<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35290622</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>FUS positive juvenile ALS-diagnostic and therapeutic insights from a 16-year-old female patient.</ArticleTitle><Pagination><StartPage>637</StartPage><EndPage>639</EndPage><MedlinePgn>637-639</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-021-01825-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Anu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Aster MIMS Hospital, Kozhikode, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sureshbabu</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3658-7467</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Aster MIMS Hospital, Kozhikode, 673016, Kerala, India. drsachins1@rediffmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikitha</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Aster MIMS Hospital, Kozhikode, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pachat</LastName><ForeName>Divya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Aster MIMS Hospital, Kozhikode, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janardhanan</LastName><ForeName>Sujith</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Science, Aster MIMS Hospital, Kozhikode, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayanan</LastName><ForeName>Rekha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Science, Aster MIMS Hospital, Kozhikode, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peter</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Neuberg Diagnostics, Vishakhapatnam, Andhra Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chindrippu</LastName><ForeName>Sobhana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Guntur Medical College, Andhra Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Merisin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aster MIMS Hospital, Kozhikode, 673016, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanlal</LastName><ForeName>Smilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aster MIMS Hospital, Kozhikode, 673016, Kerala, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>17</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35290622</ArticleId><ArticleId IdType="doi">10.1007/s13760-021-01825-9</ArticleId><ArticleId IdType="pii">10.1007/s13760-021-01825-9</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Yu X, Zhao Z, Shen H, Bing Q, Li N, Hu J (2018) Clinical and genetic features of patients with juvenile amyotrophic lateral sclerosis with fused in sarcoma (FUS) mutation. Med Sci Monitor Int Med J Exp Clin Res 24:8750</Citation></Reference><Reference><Citation>Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32(5):771</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId><ArticleId IdType="pmc">6735526</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D (2016) The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol 138:225&#x2013;238</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-802973-2.00013-6</ArticleId><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;umer D, Hilton D, Paine SM, Turner MR, Lowe J, Talbot K, Ansorge O (2010) Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 75(7):611&#x2013;618</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ed9cde</ArticleId><ArticleId IdType="pubmed">20668261</ArticleId><ArticleId IdType="pmc">2931770</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Kulkarni SD, Hegde AU, Shah KN (2018) Riboflavin treatment in genetically proven Brown&#x2013;Vialetto&#x2013;Van Laere syndrome. J Pediatr Neurosci 13(4):471</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/JPN.JPN_131_17</ArticleId><ArticleId IdType="pubmed">30937093</ArticleId><ArticleId IdType="pmc">6413615</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiner A, Zinman L, Bourque PR (2020) Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics. CMAJ 192(12):E319&#x2013;E320</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.191236</ArticleId><ArticleId IdType="pubmed">32392516</ArticleId><ArticleId IdType="pmc">7101182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bascu&#xf1;ana P, M&#xf6;hle L, Brackhan M, Pahnke J (2020) Fingolimod as a treatment in neurologic disorders beyond multiple sclerosis. Drugs R&amp;D 22:1&#x2013;1</Citation></Reference><Reference><Citation>Khalid SI, Ampie L, Kelly R, Ladha SS, Dardis C (2017) Immune modulation in the treatment of amyotrophic lateral sclerosis: a review of clinical trials. Front Neurol 25(8):486</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00486</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>